Skip to main content
. 2021 Jun 12;7:292–323. doi: 10.1016/j.bioactmat.2021.05.038

Fig. 7.

Fig. 7

TOs delivery based on imaging-guided drug delivery systems. (a) MSC membrane-coated Fe3O4@PDA–siRNA NPs for the tumor-targeting siRNA delivery. Reproduced with permission [362], Copyright 2018, American Chemical Society; (b) si-GPX4/Pt-codelivery IONPs platform for the synergistic treatment of glioblastoma. Reproduced with permission [366], Copyright 2020, American Chemical Society. (c) Targeting Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded miRNAs by CDs-mediated delivery of locked nucleic acid (LNA) for treating KSHV-induced cancers. Reproduced with permission [375], Copyright 2020, American Chemical Society.